Skip to main content

Conference Correspondent

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

[widgetkit id="1" name="CC Event Nav"]
Unsupervised Hierarchical Clustering of Surface Antigen Expression to Identify Patients with Normal Karyotype AML with Distinct Disease Characteristics and Poor Outcome
Read More
Improved Survival with Fludarabine and Timed Sequential Busulfan Regimen in Older Patients with AML or MDS
Read More
Allogeneic Transplant Leads to Markedly Improved Survival in Older Patients with Acute Myeloid Leukemia
Read More
Nivolumab with Azacytidine in Patients with Relapsed AML
Read More
Suboptimal Adherence to Guideline-Recommended Molecular Testing in Patients with Newly Diagnosed AML: Data from the Connect MDS/AML Disease Registry
Read More
Effect of Cytarabine/Anthracycline/Crenolanib Induction on MRD in Newly Diagnosed FLT3 Mutant AML
Read More
Findings from the Connect MM Registry: Changes in Treatment Patterns in Patients with Newly Diagnosed Multiple Myeloma
Read More
Carfilzomib, Pomalidomide, and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma
Read More
Elotuzumab, Lenalidomide, and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma
Read More
Response-Adapted Therapy for Newly Diagnosed Myeloma
Read More
Page 17 of 25
Results 161 - 170 of 242